TrialRMD open2025

Efficacy and safety of iguratimod in patients with primary Sjögren's syndrome: a multicentre randomised controlled trial.

Xiaochan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.